Cellebrite DI logo

Cellebrite DI

CLBT | NASDAQ
Chart Builder DCF Calculator
$11.12
-$0.41 (-3.56%)
At close: Nov 16, 2026, 4:00 PM ET
$11.27
+$0.15 (+1.35%)
After-hours: Nov 16, 2026, 7:33 PM ET
-3.56%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
63.5
-0.7 pts
Fundamentals Strong
Market Sentiment Neutral
Moat Narrow
Sector Rank #202/817 (Top 25%)

Key Statistics

Market Data

Market Cap $2.96B
1D Range
11.07 11.87
52W Range
10.44 19.24

Valuation (TTM)

PE 44.48
PB 5.12
EV/EBITDA 20.38

Valuation (NTM)

Forward PE 39.76
Forward PEG -3.52
Price Target $14.50
Loading financial charts...

Profile

Cellebrite DI Ltd. delivers specialized digital intelligence solutions crafted for legally authorized investigations. Their comprehensive DI platform enables users to efficiently gather, scrutinize, i...

Sector Technology
Employees 1,285
IPO Date Nov 6, 2020
Fiscal Year January - December

Latest News

Cellebrite DI: Continuous Innovation Including AI Can Drive Growth

1 day ago · seekingalpha.com

Cellebrite DI: Continuous Innovation Including AI Can Drive Growth
Cellebrite DI Ltd. (CLBT) Q3 2026 Earnings Call Transcript

4 days ago · seekingalpha.com

Cellebrite DI Ltd. (CLBT) Q3 2026 Earnings Call Transcript
Cellebrite DI Q3 Earnings Call Highlights

4 days ago · marketbeat.com

Cellebrite DI Q3 Earnings Call Highlights
Cellebrite DI Ltd. (CLBT) Q3 Earnings Meet Estimates

4 days ago · zacks.com

Cellebrite DI Ltd. (CLBT) Q3 Earnings Meet Estimates
Cellebrite Reports Third-Quarter 2026 Results

4 days ago · prnewswire.com

Cellebrite Reports Third-Quarter 2026 Results
Cellebrite to Report Third-Quarter 2026 Financial Results on November 12, 2026

8 days ago · prnewswire.com

Cellebrite to Report Third-Quarter 2026 Financial Results on November 12, 2026
Cellebrite Appoints Rogerio Rizzi Executive Vice President of Corporate Strategy and Development

12 days ago · prnewswire.com

Cellebrite Appoints Rogerio Rizzi Executive Vice President of Corporate Strategy and Development
Genesis Momentum Powers Cellebrite's Autumn Release: More Evidence, Deeper Insight, Broader Access for Investigations

27 days ago · prnewswire.com

Genesis Momentum Powers Cellebrite's Autumn Release: More Evidence, Deeper Insight, Broader Access for Investigations
Cellebrite publiera ses résultats financiers du troisième trimestre 2026 le 12 novembre 2026

28 days ago · prnewswire.com

Cellebrite publiera ses résultats financiers du troisième trimestre 2026 le 12 novembre 2026
Kaplan Fox is Investigating Cellebrite DI Ltd. (CLBT) for Investors Who Suffered Losses

1 month ago · newsfilecorp.com

Kaplan Fox is Investigating Cellebrite DI Ltd. (CLBT) for Investors Who Suffered Losses

Earnings

Latest Earnings
Nov 12, 2026
EPS
$0.11
Beat +16.97%
REV
$149.02M
Beat +2.19%
Next Earnings
Feb 10, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
4
Consensus
Buy
Price Target
$14.50
Upside
+30.40%
Buy (4)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.